| 1st May 2024 7:04 am |
EQS |
Redx Pharma Plc Shares now trading on JP Jenkins |
| 1st May 2024 7:00 am |
RNS |
Cancellation - Redx Pharma Plc |
| 30th Apr 2024 5:46 pm |
RNS |
Share Purchases by a PDMR |
| 30th Apr 2024 7:00 am |
RNS |
Share Purchases by PDMR’s |
| 29th Apr 2024 7:00 am |
RNS |
Update on AIM Delisting |
| 22nd Apr 2024 5:45 pm |
RNS |
TR-1: Notification of major holdings |
| 19th Apr 2024 12:18 pm |
RNS |
Result of GM, Cancellation of Admission to Trading |
| 18th Apr 2024 7:00 am |
RNS |
Share Purchases by a Director |
| 12th Apr 2024 7:00 am |
RNS |
Share Purchase by a Director |
| 10th Apr 2024 7:00 am |
RNS |
Update on Broking Arrangements |
| 8th Apr 2024 3:32 pm |
RNS |
TR-1: Notification of major holdings |
| 2nd Apr 2024 7:00 am |
RNS |
Proposed Cancellation of Admission to Trading |
| 14th Mar 2024 11:27 am |
RNS |
Result of AGM |
| 6th Mar 2024 7:00 am |
RNS |
Redx to Exhibit Three Posters at AACR |
| 28th Feb 2024 7:00 am |
RNS |
First Participant Dosed in Phase 1 Trial of RXC008 |
| 26th Feb 2024 7:00 am |
RNS |
Redx to Present at Cowen Health Care Conference |
| 23rd Feb 2024 7:00 am |
RNS |
New Grant of Options |
| 16th Feb 2024 4:50 pm |
RNS |
Notice of AGM |
| 14th Feb 2024 7:00 am |
RNS |
Statement re Press Report |
| 8th Feb 2024 1:02 pm |
RNS |
TR-1: Notification of major holdings |
| 7th Feb 2024 7:00 am |
RNS |
Redx announces sale of KRAS inhibitor program |
| 15th Dec 2023 7:00 am |
RNS |
Final Audited Results for Year Ended 30 September |
| 12th Dec 2023 7:00 am |
RNS |
Notice of Preliminary Results |
| 9th Nov 2023 7:00 am |
RNS |
Holdings in Company |
| 8th Nov 2023 1:58 pm |
RNS |
TR-1: Notification of major holdings |
| 8th Nov 2023 1:55 pm |
RNS |
TR-1: Notification of major holdings |
| 7th Nov 2023 8:10 am |
RNS |
Admission of Subscription Shares and TVR |
| 6th Nov 2023 11:22 am |
RNS |
Results of General Meeting |
| 6th Nov 2023 7:00 am |
RNS |
Redx Unveils Preclinical Data from RXC009 |
| 30th Oct 2023 7:00 am |
RNS |
Redx to present preclinical data on RXC009 at ASN |
| 18th Oct 2023 7:00 am |
RNS |
Proposed Subscription to raise c.£14.1 million |
| 22nd Aug 2023 7:00 am |
RNS |
Directorate Change |
| 21st Aug 2023 7:00 am |
RNS |
Zelasudil granted FDA Orphan Drug Designation |
| 10th Jul 2023 7:00 am |
RNS |
Extension to Termination of Convertible Loan Notes |
| 3rd Jul 2023 7:00 am |
RNS |
Directorate Change |
| 30th Jun 2023 7:00 am |
RNS |
New Grant of Options |
| 31st May 2023 7:00 am |
RNS |
Redx to present at Jefferies Healthcare Conference |
| 17th May 2023 7:00 am |
RNS |
Interim Results for the Six Months Ended 31 March |
| 12th May 2023 9:51 am |
RNS |
Discovery of Pirtobrutinib Recognised with Plaque |
| 11th May 2023 7:00 am |
RNS |
Presentation of RXC007 Preclinical Efficacy Data |
